Manske Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Manske Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Buy	23,392 +110	+0.5%	+$6.32K	0.33%	59
2026 Q1	$1.41M	Sell	23,282 -50	-0.2%	-$2.92K	0.4%	55
2025 Q4	$1.26M	Buy	23,332 +139	+0.6%	+$6.69K	0.37%	56
2025 Q3	$1.05M	Buy	23,193 +1,150	+5%	+$53.7K	0.32%	62
2025 Q2	$1.02M	Buy	22,043 +87	+0.4%	+$4.27K	0.34%	56
2025 Q1	$1.34M	Buy	21,956 +70	+0.3%	+$4.08K	0.51%	43
2024 Q4	$1.24M	Buy	+21,886	New	+$1.22M	0.49%	45

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Manske Wealth Management's BMY Position: Q2 2026 in Review

Manske Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 0.47% in Q2 2026, buying an estimated $6.32K and bringing the position to 23,392 shares worth $1.35M. The position accounts for 0.33% of the portfolio, ranked #59.

Manske Wealth Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.41M in Q1 2026. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Manske Wealth Management held 23,392 shares of Bristol-Myers Squibb worth $1.35M as of Q2 2026.
Manske Wealth Management bought 110 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.32K.
Bristol-Myers Squibb made up 0.33% of Manske Wealth Management's portfolio in Q2 2026, its #59 holding.
Manske Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Manske Wealth Management's Bristol-Myers Squibb position peaked at $1.41M in Q1 2026.
2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.